Geniculate Artery Embolization for Treatment of Osteoarthritis

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

March 12, 2025

Study Completion Date

March 12, 2025

Conditions
Osteoarthritis
Interventions
PROCEDURE

Transcatheter arterial embolization

Transcatheter arterial embolization of one or more genicular artery(ies) using Embozene™ Color-Advanced Microspheres. Embozene™ Color-Advanced Microspheres are spherical, tightly calibrated, biocompatible, non-resorbable, hydrogel microspheres coated with an inorganic perfluorinated polymer used for embolization.

DEVICE

Embozene™ Microspheres

Embozene™ Microspheres are spherical, tightly calibrated, biocompatible, nonresorbable, hydrogel microspheres coated with an inorganic perfluorinated polymer (Polyzene™-F). The microspheres intended to occlude vasculature for the purpose of blocking blood flow to a target tissue. They are available in prefilled syringes in a range of sizes suitable for embolic therapy. The microspheres are compressible to enable smooth delivery through the indicated delivery catheter and color-coded by size to allow for easy identification. 250 μm microsphere will be used and are supplied in prefilled yellow syringes.

Trial Locations (1)

10013

NYU Langone Health, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT04379700 - Geniculate Artery Embolization for Treatment of Osteoarthritis | Biotech Hunter | Biotech Hunter